Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Poli... ( STOCKHOLM span class xn-chron ....)

HOME >> BIOLOGY >> TECHNOLOGY

Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome

Date:6/30/2010

STOCKHOLM, June 30, 2010 /PRNewswire/ --

- Agreement Marks Milestone in Pharmalink's Corporate Development

Pharmalink AB, today announced that it has closed its agreement with Grifols SA for the acquisition of Pharmalink's Xepol(R) programme for the treatment of post-polio syndrome (PPS). The parties had previously announced reaching an agreement whereby Grifols would acquire all know-how and global intellectual property rights related to the use of human immunoglobulin for the treatment of (PPS) - the concept at the heart of the Xepol programme.

The agreement covers acquisition of one of Pharmalink's wholly owned subsidiaries and includes inter alia US, EU and Japan patents for the treatment of PPS with immunoglobulins, a US Orphan Drug Designation (ODD) for the use of immunoglobulin for the treatment of PPS and documentation of a number of clinical studies carried out in the recent years.

Johan Haggblad, Managing director of Pharmalink AB said: "This agreement marks a significant milestone in Pharmalink's corporate development. In developing a concept originally devised by academic researchers at the Karolinska Institute and seeing it through to being acquired by a world class company we have demonstrated the considerable value creation made possible by the Pharmalink model. We are very happy to see Grifols, our long standing partner, acquire and develop the PPS indication and to have played a part in bringing forward a treatment for this underserved condition."

Grifols will develop the PPS product opportunity using the acquired assets. Pharmalink will assist in technology trans
'/>"/>

SOURCE Pharmalink AB
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development
2. Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R)
3. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
4. Genmab Discloses Target and Development Plans for HuMax-Inflam
5. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
6. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
7. Gilde Healthcare Partners Closes EUR 150 Million European Healthcare Venture Fund
8. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
9. BioVex Closes Second Round of Series E Financing
10. Pharmaxis Closes Share Purchase Plan
11. The closest look ever at native human tissue

Post Your Comments:

(Date:5/23/2013)... May 23, 2013 Graphite Metallizing ... self-lubricating bushings mounted in stainless steel pillow blocks. ... of GRAPHALLOY with the application and installation versatility ... Pillow Blocks work exceptionally well when submerged ... hostile liquids such as acids, alkalies, hydrocarbons, black ...

(Date:5/23/2013)... May 23, 2013 PI’s new ... and provide 15 mm travel range with closed-loop ... small dimensions make these new positioners the ideal ... A vacuum rated version is also available. ... and datasheets can be found at: , ...

(Date:5/23/2013)... On April 19th the Center ... search for the growing antibiotic resistant bacteria that may ... year long study were released late last month showing ... over previous years. For those suffering from bacteria driven ... resistant bacteria in food, may eventually help breed acne ...

(Date:5/23/2013)... 2013 Verenium Corporation (Nasdaq: VRNM ), ... and commercialization of high-performance enzymes, today announced that ... present at two upcoming conferences. (Logo: ... the Second Annual Marcum LLP Microcap Conference on Thursday, ... New York City. The presentation is scheduled to begin ...

Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2 Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3 Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2 Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2 Verenium To Present At Two Upcoming Conferences 2 Verenium To Present At Two Upcoming Conferences 3

[0] Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications [0] Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI [0] Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria [0] Verenium To Present At Two Upcoming Conferences

... N.J., July 21 BioNeutral Group, Inc. ("BioNeutral") (OTC ... Science Company announced today that at ATS Labs using ... Antimicrobial passed the difficult Quantitative Disk Carrier test ... difficile (C.diff) present in this test ...

... , , PALO ALTO, Calif., July 21, ... third quarter of its fiscal year 2009 after 1:00 p.m. Pacific Time ... of its investor conference call to review those quarterly results is scheduled ... , That live webcast can be accessed from Varian, ...

... , , KENILWORTH, N.J., July 21 ... for the 2009 second quarter. , , ... given us the strength to again power through tough challenges - delivering ... Fred Hassan, chairman and CEO. , , ...

BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.Varian, Inc. to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results Schering-Plough Reports Financial Results for 2009 Second Quarter

(Date:5/22/2013)... National Lung Screening Trial (NLST) investigators also conclude ... mortality with low-dose computed tomography (LDCT) versus chest ... primary paper is achievable at experienced screening centers ... more information to share with their patients about ... screening following today,s publication in the New ...

(Date:5/22/2013)... 2013)The omega 3 fatty acids in fish oil have ... so that the American Heart Association currently recommends eating ... fatty varieties rich in omega 3s. However, the mechanism ... a new study, scientists led by Jason R. Carter ... by providing evidence that fish oil might specifically counteract ...

(Date:5/22/2013)... Legionella pneumophila bacteria is responsible for legionellosis, an ... to infect us, this pathogen has developed a complex ... in our cells, thus avoiding these acting against the ... research centre, CIC bioGUNE, in which teams from the ... the National Supercomputation Centre in Barcelona (BSC) have also ...

Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2 NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3 Fish oil may help the heart beat mental stress 2 Mechanism discovered which aids Legionella to camouflage itself in the organism 2

[0] NLST: CT detects twice as many lung cancers as X-ray at initial screening exam [1] Fish oil may help the heart beat mental stress [0] Mechanism discovered which aids Legionella to camouflage itself in the organism

... This press release is available in French ... kind, combines two complementary analytical brain imaging techniques, to provide ... the autistic brain. The study, published in the April issue ... by researchers at The Montreal Neurological Institute and Hospital ...

... It,s illegal for health products with medical formulations to be ... on animals ― a situation that has serious ethical and ... by Prof. Amit Gefen of Tel Aviv University,s Faculty of ... be needed for the necessary experimental trials. Dr. Gefen,s ...

... The six sponsoring societies for the meeting ... The American Physiological Society, American Society for Biochemistry ... American Society for Nutrition, and American Society for ... some of the science being presented April 24-28, ...

Cached Biology News:Dual approach gives a more accurate picture of the autistic brain 2 Dual approach gives a more accurate picture of the autistic brain 3 A lab rat -- created in the lab 2 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 2 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 3 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 4

Dual approach gives a more accurate picture of the autistic brain A lab rat -- created in the lab Selected highlights of the research being presented at the Experimental Biology 2010 meeting

This antibody detects cdc42 on SDS-PAGE immunoblots....

Goat polyclonal to Nebraska Calf Diarrhea Virus (FITC) ( Abpromise for all tested applications). Antigen: Bovine (Nebraska Calf Diarrhea Virus)....

DNA fragmentation factor & Inhibitor of CAD...

Rabbit polyclonal to Methionine Aminopeptidase 2 ( Abpromise for all tested applications). entrezGeneID: 10988 SwissProtID: P50579...

Biology Products:

Rabbit Anti-cdc42 / Rac Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents Goat Anti-Human Nebraska Calf Diarrhea Virus Polyclonal Antibody, FITC Conjugated from Abcam Anti-Human DFF45 / ICAD (NT) Polyclonal Antibody, Unconjugated from Cell Sciences Rabbit Anti-Methionine Aminopeptidase 2 Polyclonal Antibody, Unconjugated from Abcam